Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Abstract Purpose Very few data exist on the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and eating disorders. The study aimed to evaluate the presence of binge eating disorder (BED), in MASLD subjects. Methods Demographic, clinical investigation, anthropometr...
Main Authors: | Lucia Brodosi, Michele Stecchi, Francesca Marchignoli, Elisabetta Lucia, Lucia Magnani, Valeria Guarneri, Maria Letizia Petroni, Giulio Marchesini, Loris Pironi |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2023-12-01
|
Series: | Eating and Weight Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40519-023-01628-2 |
Similar Items
-
Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01) -
Uric acid as a potential marker of cardiometabolic risk in children and adolescents with metabolic dysfunction associated steatotic liver disease
by: Katarzyna Zdanowicz, et al.
Published: (2024-09-01) -
Predicting cardiometabolic disease in medical students using FibroScan and 30-year Framingham risk scores
by: Charu Sharma, et al.
Published: (2024-09-01) -
Assessment of liver fibrosis: Noninvasive means
by: Poynard Thierry, et al.
Published: (2008-01-01) -
On Psychological Peculiarities of Atypical Binge-Eating
by: Lesia Lymar
Published: (2018-01-01)